DE69519654T2 - htFIIIA Gen - Google Patents

htFIIIA Gen

Info

Publication number
DE69519654T2
DE69519654T2 DE69519654T DE69519654T DE69519654T2 DE 69519654 T2 DE69519654 T2 DE 69519654T2 DE 69519654 T DE69519654 T DE 69519654T DE 69519654 T DE69519654 T DE 69519654T DE 69519654 T2 DE69519654 T2 DE 69519654T2
Authority
DE
Germany
Prior art keywords
htfiiia
gene
sequence shown
base sequence
shown under
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69519654T
Other languages
English (en)
Other versions
DE69519654D1 (de
Inventor
Tsutomu Fujiwara
Satoshi Takeda
Yoshikazu Shimada
Kouichi Ozaki
Shin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of DE69519654D1 publication Critical patent/DE69519654D1/de
Application granted granted Critical
Publication of DE69519654T2 publication Critical patent/DE69519654T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69519654T 1994-09-05 1995-09-05 htFIIIA Gen Expired - Fee Related DE69519654T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6211022A JP2946019B2 (ja) 1994-09-05 1994-09-05 ｈＴＦＩＩＩＡ遺伝子

Publications (2)

Publication Number Publication Date
DE69519654D1 DE69519654D1 (de) 2001-01-25
DE69519654T2 true DE69519654T2 (de) 2001-05-17

Family

ID=16599063

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69519654T Expired - Fee Related DE69519654T2 (de) 1994-09-05 1995-09-05 htFIIIA Gen

Country Status (8)

Country Link
US (1) US5808030A (de)
EP (1) EP0704526B1 (de)
JP (1) JP2946019B2 (de)
KR (1) KR960010861A (de)
CN (1) CN1134460A (de)
AT (1) ATE198218T1 (de)
CA (1) CA2157531A1 (de)
DE (1) DE69519654T2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2946019B2 (ja) * 1994-09-05 1999-09-06 大塚製薬株式会社 ｈＴＦＩＩＩＡ遺伝子
FR2785618B1 (fr) * 1998-11-10 2002-12-13 Hoechst Marion Roussel Inc GENE HUMAIN htfIIIA ET LA PROTEINE CODEE hTFIIIA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2946019B2 (ja) * 1994-09-05 1999-09-06 大塚製薬株式会社 ｈＴＦＩＩＩＡ遺伝子

Also Published As

Publication number Publication date
JP2946019B2 (ja) 1999-09-06
US5808030A (en) 1998-09-15
EP0704526A1 (de) 1996-04-03
DE69519654D1 (de) 2001-01-25
JPH0870870A (ja) 1996-03-19
KR960010861A (ko) 1996-04-20
CA2157531A1 (en) 1996-03-06
CN1134460A (zh) 1996-10-30
EP0704526B1 (de) 2000-12-20
ATE198218T1 (de) 2001-01-15

Similar Documents

Publication Publication Date Title
ATE125867T1 (de) Fibronektinbindungsprotein und dessen herstellung.
EP1439230A3 (de) Menschliche transmembranprotein TMP-2 gen
WO1999053061A3 (en) Tumor associated nucleic acids and uses therefor
PL331005A1 (en) Regulating dna of hamster's ef-1alpha transcription
IL124728A0 (en) Diagnosis and treatment of aur-1 and/or aur-2 related disorders
EP0731636A4 (de) Apoptosis modulierende proteine, sie kodierende dns und verfahren zu ihrer verwendung
EP0205475A4 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
IL135688A0 (en) Human checkpoint kinase, hcds1, compositions and methods
DE69532033D1 (de) Für ein fibroblasten-aktivierungsprotein kodierende nukleinsäure und verwendungen dafür
ATE120494T1 (de) Fibronectinbindungsprotein und dessen herstellung.
DE69934239D1 (de) Ly6h-gen
EP0773290A3 (de) Proteinanaloge des LDL-Rezeptors und deren kodierende Gene
ATE198218T1 (de) Htfiiia gen
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
PT648836E (pt) Transactivador do mhc de classe ii (ciita) e suas utilizacoes
ZA98656B (en) Lage-1 tumer associated nucleic acids
HUP9802289A2 (hu) Limfocita specifikus interferon szabályozó faktor (LSIRF) polipeptideket kódoló gének
TW342413B (en) Novel toxins isolated from Bracon Hebetor
WO1997026276A3 (en) Vertebrate fringe proteins
ATE348109T1 (de) Das gen prv-1 und dessen verwendung
ATE124722T1 (de) Für das plazentaprotein 9 (pp9) kodierende cdna, ihre isolierung und verwendung.
DE60021707D1 (de) Beta-primeverosidase gen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee